Prices re-read October 15, 2026Methodology v4.1How we score →
Compare Providers
Home / Editorial Board / Dr. Parmis

Released: ·Last reviewed: ·Methodology v4.1

Researched By
Medical Researcher · Western University of Health Sciences
Last medically reviewed: October 15, 2026 · This page is informational and does not constitute medical advice.
This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.

Dr. Parmis

Medical Researcher · Western University of Health Sciences

Dr. Parmis is a medical researcher (Western University of Health Sciences) and the editorial lead who researches Transparent Peptide pages. She leads evidence synthesis: locating primary studies, grading evidence quality, and separating human clinical data from animal and laboratory findings on medication and peptide pages. Clinical content is then medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC). She is not compensated based on any provider's sales.

Credentials & verification

Role
Medical Researcher and editorial lead
Review scope
Research synthesis and evidence review on every page; preparation of provider scores for review.
Affiliation
Western University of Health Sciences

Conflict disclosure

Dr. Parmis is not compensated based on any reviewed provider's sales. The publisher’s relationship with NexLife is described on our conflicts-of-interest page. See our conflicts-of-interest policy.

How the dates on this page work. Manufacturer self-pay prices were re-read on 15 October 2026: NovoCare’s Wegovy page and Lilly’s Zepbound savings page. Foundayo prices are carried from LillyDirect pages archived 25 September 2026, because lilly.com blocked automated reads. Figures captured from telehealth provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row or a dated notice says so. We do not restamp a figure we have not re-read.